secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-07-03T23:59:59+00:00
Accession:  0001104659-24-077791
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio enters ATM equity facility for up to $7.35M in common stock sales
----------------------------------------------------------------------

- Entry into ATM Agreement with Chardan Capital Markets and Craig-Hallum Capital Group for at-the-market offerings.
- Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $7,350,000.
- Sales agents receive fixed commission rate of up to 3.0% of gross proceeds.
- Shelf registration statement on Form S-3 filed on July 3, 2024, must be effective before sales can occur.
- Company has no obligation to sell shares and may suspend offerings at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/0001104659-24-077791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000110465924077791/tm2418848d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-077791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer